BRCA1 and breast carcinoma: The HRD-algorithm used in ovarian cancer clinical trials (Telli2016) was, however, generated using breast cancer samples or a mixture of breast cancer and ovarian cancer samples using BRCA1/2 mutation as the sole determinant of HRD, and BRCAwt status as HRP8–10.